RCM Technologies, Inc. (NNM:RCMT) announces the release of its "Validation 2.0" solution offering for the next generation of Computer Systems Validation (CSV). The Validation 2.0 solution combines RCM's proprietary process with a best-of-breed Application Lifecycle Management tool, such as Mercury Quality Center, to form an integrated, customized CSV offering. This offering comprehensively addresses end-user challenges related to FDA compliance and effectively allows companies to:

RCM Technologies, Inc. (NNM:RCMT) announces the release of its "Validation 2.0" solution offering for the next generation of Computer Systems Validation (CSV). The CSV process is required by the Food and Drug Administration for Life Sciences companies.

The Validation 2.0 solution combines RCM's proprietary process with a best-of-breed Application Lifecycle Management tool, such as Mercury Quality Center, to form an integrated, customized CSV offering. This offering comprehensively addresses end-user challenges related to FDA compliance and effectively allows companies to:

-- electronically manage requirements,

-- link requirements to tests while tests are being written,

-- electronically control the workflow--tests that have prerequisites cannot be executed until the prerequisites are met,

-- securely document which user ID was used to execute each test step,

-- electronically manage test results, insuring that evidence is never separated from the associated test step and

-- facilitate the review process by eliminating tedious checks and balances.

"Computer Systems Validation is an expensive, labor-intensive process that needs to be streamlined, and the Validation 2.0 offering is an integrated process and software solution that reduces costs and improves compliance," said James Sigountos, RCM Senior Manager. "By utilizing our solution we expect to reduce our customers' overall compliance costs by 30%."

Combining RCM's many years of experience in the Computer Systems Validation arena with best-of-breed tools, Validation 2.0 enables companies to eliminate the tedious and costly task of creating, managing, reviewing, approving and storing massive quantities of paper test protocols and paper attachments.

RCM's areas of expertise include quality assurance, Part 11, validation and qualification, and enterprise application software implementation. RCM is a recognized leader in bringing solutions to the Life Sciences industry by integrating its in-depth expertise in IT, Engineering and Quality and Compliance services.

About RCM

RCM Technologies, Inc. is a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of information technology and engineering services. RCM has been an innovative leader in the design, development and delivery of these solutions to commercial and government sectors for more than 35 years. RCM's offices are located in major metropolitan centers throughout North America. Additional information can be found at www.rcmt.com.

The Statements contained in this release that are not purely historical are forward-looking statements within the Private Securities Litigation Reform Act of 1995 and are subject to various risks, uncertainties and other factors that could cause the Company's actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. Forward looking statements include, but are not limited to, those relating to demand for the Company's services, expected demand for our services and expectations regarding our revenues, the Company's ability to continue to utilize goodwill, to continue to increase gross margins, to achieve and manage growth, to develop and market new applications and services, risks relating to the acquisition and integration of acquired businesses, demand for new services and applications, timing of demand for services, industry strength and competition and general economic factors. Investors are directed to consider such risks, uncertainties and other factors described in documents filed by the Company with the Securities and Exchange Commission.